GOLDSTEIN DOV A MD bought BIOA
April 23, 2026 · Form 4 insider transaction
GOLDSTEIN DOV A MD bought 3,542 shares of BioAge Labs, Inc. at $4.38 per share, a transaction worth $15.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,542
Price
$4.38
Total value
$15.5K
InsiderGOLDSTEIN DOV A MD
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 23, 2026
Filing dateApril 24, 2026
Shares owned after36,575
OwnershipDirect
10b5-1 planNo
AmendedNo